Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish.
Studies suggest that lower stroke risk associated with newer antidiabetic therapies is not due to the drugs' tighter glycemic control. So, what is the mechanism?
The timing of moderate to vigorous physical activity was associated with a lower risk for mortality and CVD in adults with obesity, including those with type 2 diabetes.